COOL LOI = strong move Yesterday COOL announced LOI with Akome - a developer of psychedelic-based pharmaceuticals for rare diseases and mental disorders targeting treatments for Cluster Headaches (CH), Alzheimer's Disease (AD), and Depression.
Hovering around the $1 mark and has been for several months. Looking for next leg up.